Generic Name: atomoxetine (AT oh mox e teen)
Brand name: Strattera®
All FDA warnings are at the end of this fact sheet. Please consult them before taking this medication.
Atomoxetine is a prescription medication that is used to treat attention-deficit hyperactivity disorder (ADHD).
Symptoms of ADHD interfere can affect a person’s ability to function at school, work or in social settings. Symptoms can include:
Hyperactivity is less common in adults. A person may have severe inattention without hyperactivity or impulsivity.
Atomoxetine is used in addition to non-medication treatments to manage ADHD symptoms.
It may take several weeks before you notice the full benefits of this medication. It is important to continue taking atomoxetine as directed, even if you do not notice immediate improvement.
If you are planning on becoming pregnant, notify your health care provider to best manage your medications. People living with ADHD who wish to become pregnant face important decisions. Untreated ADHD has risks for the fetus as well as the mother. It is important to discuss the risks and benefits of treatment with your doctor and caregivers.
Caution is advised with breastfeeding since it is not known if atomoxetine passes into human breast milk.
Atomoxetine is usually taken one to two times per day with or without food.
The dose usually ranges from 20 mg to 100 mg. Only your health care provider can determine the correct dose for you.
Capsules should be swallowed whole, not crushed, chewed or opened.
Use a calendar, pillbox, alarm clock, or cell phone alert to help you remember to take your medication. You may also ask a family member or friend to remind you or check in with you to be sure you are taking you medication.
If you miss a dose of atomoxetine, take it as soon as you remember, unless it is closer to the time of your next dose. Discuss this with your health care provider. Do not double your next dose or take more than what is prescribed.
Avoid drinking alcohol or using illegal drugs while you are taking this medication. They may decrease the benefits (e.g., worsen your condition) and increase adverse effects (e.g., sedation) of the medication.
If an overdose occurs call your doctor or 911. You may need urgent medical care. You may also contact the poison control center at 1-800-222-1222.
A specific treatment to reverse the effects of atomoxetine does not exist.
Common side effects
Rare side effects
Serious side effects
There are no known problems associated with long term use of atomoxetine.
The following medications may increase the levels and effects of atomoxetine:
Atomoxetine should not be taken with or within 2 weeks of monoamine oxidase inhibitor antidepressants (MAOIs), including phenelzine (Nardil®), Tranylcypromine (Parnate®), selegiline (Emsam®), and isocarboxazid (Marplan®) or the antibiotic linezolid (Zyvox®). Taking atomoxetine with or within 2 weeks of MAOIs can result in seizures, fever or dangerously high blood pressure that can lead to death.
Because of atomoxetine’s possible effect on blood pressure, it should be used cautiously with other medications that increase or decrease blood pressure. Medications for asthma/difficulty breathing (e.g., albuterol) can increase the risk of high blood pressure and rapid heart rate (tachycardia) when taking atomoxetine.
It may take 4-8 weeks to get the maximum benefit once the right dose is determined. However, improvements in some symptoms may occur sooner.
Suicidal Thoughts or Actions in Children, Teens, and Young Adults
Last Reviewed: January 2024
Provided by
Important Disclosure: This information is being provided as a community outreach effort of the American Association of Psychiatric Pharmacists. This information is for educational and informational purposes only and is not medical advice. This information contains a summary of important points and is not an exhaustive review of information about the medication. Always seek the advice of a physician or other qualified medical professional with any questions you may have regarding medications or medical conditions. Never delay seeking professional medical advice or disregard medical professional advice as a result of any information provided herein. The American Association of Psychiatric Pharmacists disclaims any and all liability alleged as a result of the information provided herein.
©2023 The American Association of Psychiatric Pharmacists (AAPP) and the National Alliance on Mental Illness (NAMI). AAPP and NAMI make this document available under the Creative Commons Attribution-NoDerivatives 4.0 International License. Last Updated: January 2016.
NAMI HelpLine is available M-F, 10 a.m. – 10 p.m. ET. Call 800-950-6264,
text “helpline” to 62640, or chat online. In a crisis, call or text 988 (24/7).